Хантико

Хантико (Fingolimod Hydrochloride) is an oral medication used to reduce the frequency of relapses in multiple sclerosis. It belongs to a class of drugs that modulate the immune system. Always consult a healthcare professional before use.

Fingolimod Hydrochloride, sold as Хантико, is primarily used to treat relapsing forms of multiple sclerosis (MS) in adults. It helps reduce the frequency of flare-ups and slows the progression of physical disability. The medication works by affecting the immune system to prevent it from attacking nerve fibers in the brain and spinal cord. It is not a cure but may help manage symptoms and improve quality of life.

Хантико may help reduce the number of MS relapses and delay the progression of disability. Users often report fewer flare-ups and a steadier daily routine. Some people notice improved mobility or reduced fatigue over time. Individual responses vary, and effects may take weeks or months to become noticeable.

Хантико should be taken exactly as prescribed by a healthcare provider. Regular monitoring, including heart rate checks, is recommended, especially after the first dose. Avoid live vaccines while using this medication. Inform your doctor about any heart, liver, or lung conditions before starting treatment.

Хантико can interact with medications that affect heart rhythm, such as certain antidepressants or antiarrhythmics. Combining it with vaccines, especially live ones, may reduce effectiveness or increase risk. Alcohol and other immune-modulating drugs may also interact; discuss all current medications with your doctor.